Golden
Ysios Capital

Ysios Capital

Ysios Capital invests in companies in the biotechnology industry focused on therapeutics, human healthcare, and life science companies.

Ysios Capital is a biotechnology investment firm in Spain. Established in 2008, Ysios Capital has over € 200 million in resources under administration through its two assets: Ysios BioFund I (€65 M) and Ysios BioFund II Innvierte (€ 126M). They expect to make an incentive by giving capable entrepreneurs the assets and tools to make progress in changing intellectual capital and logical information into effective companies. Their group is composed of experienced professionals with broad experience in contributing and building healthcare and biotechnology businesses.

This venture capital gives private equity financing to early and middle stage healthcare and life science companies. They focus on the biotechnology industry, with a focus on therapeutics. 



Timeline

2008

Founded

Funded Companies

12 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.

BioClin Therapeutics is a San Ramon, California-based company.

People

Name
Role
LinkedIn

Guillem Laporta

Principal



Joel Jean Mairet

Managing Partner and Co - Founder



Lance Berman

Venture Partner



Raul Martin

Partner



Claudia D’Augusta

Venture Partner



Cristina Garmendia

General Partner



Miriam Cortés

Executive Assistant & Corporate Communications, Office manager



Paula Olazábal

Partner



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

AM Pharma







Anaconda BioMed







Aura Biosciences







Babyscripts







CVRx







Galecto Biotech







Minoryx Therapeutics







Rainier Therapeutics







SANIFIT







Xeltis







References